Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q3 product sales rose 56%, the quarter was profitable and cash-flow positive, and shares gained about 28% through November 18; the extended price move warrants caution.
Loading chart data...
Idea window: 11/19/2026 – 11/26/2026Sector: Healthcare
AI Analyst Overview
Last Price
$13.09
Market Cap
$462.14M
1D Return
-2.68%
YTD Return
+70.00%
Loading chart data...
Valuation Metrics
P/E
571.6
P/B
9.3
P/S
7.0
EV/EBITDA
174.5
Div Yield
—
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Nov 19 | Nov 26 | FENC | Fennec Pharmaceuticals Inc. | Q3 product sales rose 56%, the quarter was profitable and cash-flow positive, and shares gained about 28% through November 18; the extended price move warrants caution. | Active | +0.0% |